GlaxoSmithKline: Phobia, Social trials

The registry lists 11 Phobia, Social studies with GlaxoSmithKline as lead sponsor. 0 are open to participants now and 0 have results posted.

Phase 1 4Phase 2 4Phase 3 2No phase 1(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Special Drug Use Investigation for PAXIL (Paroxetine) Social Anxiety Disorder (Long-term)CompletedNCT01376271
• A Study To Compare The Putative Anxiolytic Effect Of 2 New Drugs In Subjects With Social Anxiety DisorderCompletedNCT00555139Phase 1
• A Study To Evaluate The Effect Of GW876008 On The Pharmacokinetics Of Oral Contraceptive PillsTerminatedNCT00508911Phase 1
• A Study To Compare Emotional Changes In Subjects With Social Anxiety DisorderCompletedNCT00470483Phase 1
• A Combination Therapy In Patients With Social Anxiety DisorderCompletedNCT00403962Phase 2
• Treatment Of Patients With Social Anxiety DisorderCompletedNCT00397722Phase 2
• PET (Positron Emission Tomography)/Public Speaking Study With A Combination Of 2 Medications In Social Anxiety PatientsCompletedNCT00343707Phase 2
• fMRI Study Comparing BOLD Activation Patterns Using GW679769 In Subjects With Social Anxiety DisorderCompletedNCT00332046Phase 1
• Social Anxiety Disorder Study Of ParoxetineCompletedNCT00318669Phase 3
• A Study Of A New Medicine (GW679769) For The Treatment Of Social Anxiety DisorderCompletedNCT00273039Phase 2
• Long-term Study Of Paroxetine in Women and MenCompletedNCT00264654Phase 3